Will Data From Liver Disease, Sickle Cell Disease Trials Give Axcella A Boost?

Shares of Axcella Health Inc. (AXLA) have been dismally performing since their listing on the NASDAQ on May 9, 2019. The stock is down more than 70 percent over the last 1 year.

from RTT - Biotech https://ift.tt/2TpubTW
via IFTTT